泰華天(tian)然(ran)生(sheng)物制藥(yao)有(you)限公(gong)司(si)成立于1993年,是一家集藥(yao)源種植基地(di)、原(yuan)料藥(yao)和(he)中(zhong)成藥(yao)的(de)生(sheng)產、銷售為一體的(de)現代化高新(xin)制藥(yao)企(qi)業。公(gong)司(si)生(sheng)產基地(di)位于素有(you)“天(tian)然(ran)藥(yao)物寶(bao)庫”之稱的(de)秦嶺南(nan)麓陜西省商洛市洛南(nan)縣,總用地(di)面積兩萬余平米。
公司(si)現(xian)設有(you)藥(yao)(yao)(yao)(yao)源種(zhong)(zhong)(zhong)植(zhi)(zhi)基地(di)(di)、生產(chan)基地(di)(di)、中(zhong)(zhong)(zhong)(zhong)成藥(yao)(yao)(yao)(yao)營銷(xiao)(xiao)中(zhong)(zhong)(zhong)(zhong)心、原(yuan)(yuan)(yuan)料藥(yao)(yao)(yao)(yao)海(hai)外(wai)營銷(xiao)(xiao)中(zhong)(zhong)(zhong)(zhong)心四個事業部,生產(chan)藥(yao)(yao)(yao)(yao)品(pin)涵蓋(gai)了腫(zhong)瘤(liu)科、消化(hua)科、婦科、皮膚科等(deng)多個領(ling)域。原(yuan)(yuan)(yuan)料藥(yao)(yao)(yao)(yao)海(hai)外(wai)營銷(xiao)(xiao)中(zhong)(zhong)(zhong)(zhong)心以(yi)高(gao)(gao)三尖(jian)(jian)杉酯堿、紫(zi)杉醇(chun)等(deng)抗腫(zhong)瘤(liu)原(yuan)(yuan)(yuan)料藥(yao)(yao)(yao)(yao)為核心,產(chan)品(pin)主要(yao)銷(xiao)(xiao)往(wang)歐(ou)盟(meng)、以(yi)色列、俄羅斯、韓國(guo)等(deng)發達國(guo)家和(he)(he)地(di)(di)區,受到境(jing)外(wai)客戶的高(gao)(gao)度贊譽和(he)(he)支持;中(zhong)(zhong)(zhong)(zhong)成藥(yao)(yao)(yao)(yao)營銷(xiao)(xiao)中(zhong)(zhong)(zhong)(zhong)心以(yi)便通片(pian)、芪棗顆(ke)粒、棗仁安神顆(ke)粒、杜仲(zhong)平(ping)壓片(pian)等(deng)內(nei)科用(yong)(yong)藥(yao)(yao)(yao)(yao)為龍(long)頭,銷(xiao)(xiao)售(shou)網絡覆(fu)蓋(gai)全(quan)國(guo)各個省份,并且獲得廣大患者的一(yi)致好評和(he)(he)信賴;藥(yao)(yao)(yao)(yao)源種(zhong)(zhong)(zhong)植(zhi)(zhi)基地(di)(di)主要(yao)負責公司(si)自有(you)產(chan)品(pin)原(yuan)(yuan)(yuan)藥(yao)(yao)(yao)(yao)材(cai)基地(di)(di)建(jian)設與供給,現(xian)有(you)原(yuan)(yuan)(yuan)料藥(yao)(yao)(yao)(yao)種(zhong)(zhong)(zhong)植(zhi)(zhi)基地(di)(di)3000余畝,主要(yao)植(zhi)(zhi)株為曼迪亞紅(hong)豆杉和(he)(he)中(zhong)(zhong)(zhong)(zhong)國(guo)粗榧,為公司(si)原(yuan)(yuan)(yuan)料藥(yao)(yao)(yao)(yao)紫(zi)杉醇(chun)和(he)(he)高(gao)(gao)三尖(jian)(jian)杉酯堿提(ti)供了優(you)質的天然原(yuan)(yuan)(yuan)料,同時科學利用(yong)(yong)土(tu)地(di)(di)資(zi)源,在基地(di)(di)共種(zhong)(zhong)(zhong)植(zhi)(zhi)連翹、杜仲(zhong)、苦參等(deng)藥(yao)(yao)(yao)(yao)材(cai)數十萬株。除此之(zhi)外(wai),公司(si)在秦嶺儲備林地(di)(di)一(yi)萬余畝,并逐(zhu)步推(tui)進中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)材(cai)生態種(zhong)(zhong)(zhong)植(zhi)(zhi)和(he)(he)野生撫育計劃,在加強中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)材(cai)道地(di)(di)產(chan)區環境(jing)保(bao)護(hu)的同時,為大家提(ti)供療效更為突(tu)出(chu)的優(you)質天然藥(yao)(yao)(yao)(yao)材(cai)。
公司生(sheng)產線已(yi)全部通(tong)過(guo)國家(jia)新版GMP認證,中(zhong)藥(yao)(yao)飲片、配方(fang)顆粒(li)、保健食品事業部已(yi)處(chu)于籌建中(zhong),預計2020年(nian)將(jiang)實(shi)現各個(ge)板塊(kuai)的(de)投產。公司還將(jiang)在傳(chuan)統的(de)原料藥(yao)(yao)和(he)中(zhong)成藥(yao)(yao)基(ji)礎上,加大(da)藥(yao)(yao)物的(de)科研力(li)度,并從(cong)植(zhi)物單體開發、化(hua)學藥(yao)(yao)物合成及(ji)成藥(yao)(yao)衍(yan)生(sheng)物的(de)科學研發做出更多的(de)努力(li)。預計2025年(nian),泰華制藥(yao)(yao)將(jiang)實(shi)現以種植(zhi)、生(sheng)產、研發、銷(xiao)售為一(yi)體的(de)完整(zheng)產業鏈覆(fu)蓋,屆(jie)時(shi)泰華醫(yi)藥(yao)(yao)健康產業將(jiang)發力(li),為社會和(he)患者(zhe)提供(gong)更豐(feng)富的(de)產品、更優質的(de)服務(wu)。